Indication
Hepatic veno-occlusive disease
Hepatic veno-occlusive disease, also known as sinusoidal obstruction syndrome, is a potentially life-threatening vascular liver disorder primarily affecting patients exposed to toxic insults, most notably high-dose conditioning chemotherapy or radiation preceding hematopoietic stem cell transplantation. Read more about Hepatic veno-occlusive disease
1 drugs 1 manufacturers
Drugs that treat it
Common Hepatic veno-occlusive disease therapies.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonHepatic veno-occlusive disease, also known as sinusoidal obstruction syndrome, is a potentially life-threatening vascular liver disorder primarily affecting patients exposed to toxic insults, most notably high-dose conditioning chemotherapy or radiation preceding hematopoietic stem cell transplantation.
The condition is triggered by toxic injury to hepatic sinusoidal endothelial cells and centrilobular hepatocytes, leading to nonthrombotic occlusion of terminal hepatic venules, sinusoidal congestion, and impaired intrahepatic blood flow.
Clinically, it is characterized by tender hepatomegaly, rapid fluid retention manifesting as ascites and unexplained weight gain, and hyperbilirubinemia, which can progress to multiorgan dysfunction in severe cases.
- cancer.gov
Hepatic veno-occlusive disease, also known as sinusoidal obstruction syndrome, is a potentially life-threatening vascular liver disorder primarily affecting patients exposed to toxic insults, most notably high-dose conditioning chemotherapy or radiation preceding hematopoietic stem cell transplantation Clinically, it is characterized by tender hepatomegaly, rapid fluid retention manifesting as ascites and unexplained weight gain, and hyperbilirubinemia, which can progress to multiorgan dysfuncti...
- nih.gov
Hepatic veno-occlusive disease, also known as sinusoidal obstruction syndrome, is a potentially life-threatening vascular liver disorder primarily affecting patients exposed to toxic insults, most notably high-dose conditioning chemotherapy or radiation preceding hematopoietic stem cell transplantation
- nih.gov
The condition is triggered by toxic injury to hepatic sinusoidal endothelial cells and centrilobular hepatocytes, leading to nonthrombotic occlusion of terminal hepatic venules, sinusoidal congestion, and impaired intrahepatic blood flow Clinically, it is characterized by tender hepatomegaly, rapid fluid retention manifesting as ascites and unexplained weight gain, and hyperbilirubinemia, which can progress to multiorgan dysfunction in severe cases
- nih.gov
The condition is triggered by toxic injury to hepatic sinusoidal endothelial cells and centrilobular hepatocytes, leading to nonthrombotic occlusion of terminal hepatic venules, sinusoidal congestion, and impaired intrahepatic blood flow
- nih.gov
The condition is triggered by toxic injury to hepatic sinusoidal endothelial cells and centrilobular hepatocytes, leading to nonthrombotic occlusion of terminal hepatic venules, sinusoidal congestion, and impaired intrahepatic blood flow
Personalize your experience
Follow Hepatic veno-occlusive disease and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.